Archimedes™ APD System
End-Stage Renal Disease (ESRD) requiring peritoneal dialysis
DevelopmentActive
Key Facts
Indication
End-Stage Renal Disease (ESRD) requiring peritoneal dialysis
Phase
Development
Status
Active
Company
About Simergent
Simergent is a private, pre-revenue medical device startup founded in 2019 and based in San Francisco, developing the Archimedes™ automated peritoneal dialysis system. The device is engineered to be more patient-centric, with features targeting reduced peritonitis risk, lower fill/drain pressures, minimal setup time, and enhanced mobility to allow a more normal life. Led by a team with deep expertise in PD device development and nephrology, and backed by incubators and venture capital, the company is positioning itself to capture share in the large and growing global home dialysis market, particularly in cost-sensitive emerging regions.
View full company profile